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Surgical treatment decision making: 
how Chinese women with breast cancer 
choose treatment
Key Messages
1. Most women are so over-
whelmed by the diagnosis of 
breast cancer that they feel 
paralysed.
2. Chinese women liken treatment 
decision making (TDM) to 
gambling—they feel uncertain 
during the TDM process and 
suffer from indecisiveness.
3. Chinese women make trade-offs 
for survival, which is considered 
the highest stake. Many reported 
they were choosing between 
cosmesis and survival.
4. Coping with uncertainty during 
and after the treatment was an 
ongoing problem for many 
women.
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Introduction
Modified radical mastectomy (MRM) yields similar survival rates to breast 
conservation therapy (BCT) in early-stage breast cancer (BC),1 hence quality of 
life often dictates treatment choice. Multiple treatment alternatives and increasing 
expectations of patient participation in medical care2 mean that women diagnosed 
with BC are confronted with difficult surgical treatment choices. A diagnosis of 
BC forces a woman to take several extremely stressful decisions: treatment or 
no treatment, MRM or BCT, and if MRM, then breast reconstruction or not. 
Each decision is complicated by uncertainties regarding tumour stage and type 
and likely adjuvant therapies, among others. Women must decide quickly while 
struggling with fear, uncertainty, and ambiguity.
 Two paradigms have been used to examine perceptions in women confronting 
BC3: normative approaches, which assume rationality (analytic processing) as the 
gold standard for how individuals should make decisions and hold that rational 
processes lead to optimal decisions. In contrast, naturalistic approaches argue 
that people use automatic, intuitive processing to make real-life decisions and 
study decision making in real-world contexts.
 Most studies are based on analytic processing assumptions3-5 and consistently 
indicate exceptions to logical, deliberative decision making. Using rational 
treatment decision making (TDM) in BC can be more cognitively and emotionally 
taxing, error prone, thus causing guilt and lowering satisfaction.6
 Alternative perspectives on how people make decisions in real-world 
contexts, such as medical decisions, describe TDM processes as opposed to 
optimal decisions,6 using in-depth knowledge and understanding of the lived 
experience of TDM. This study describes the TDM process in Chinese women 
with BC.
Methods
This study was conducted from October 2000 to June 2003. A grounded theory 
approach was chosen because it explores experiential aspects of human behaviour 
and the underlying processes.7 Grounded theory is most useful for developing 
new theoretic starting points.
Sample and procedure
This study involved the two public breast centres in Hong Kong, following ethics 
approval. Cantonese-speaking Hong Kong Chinese resident women 21 years or 
older who had recently been diagnosed with BC were targeted. These inclusion 
criteria for interviewees gave an initial starting point for data collection. Samples 
in grounded theory studies should not be totally pre-specified, but allowed to 
evolve once fieldwork begins.6 Constant comparison (comparing new data to the 
emerging categories) is used to refine the categories. A heterogeneous sample 
is therefore essential for confirming or disconfirming the working hypotheses 
under which the theory holds. Theoretic saturation (no new material generated 
over four consecutive interviews) determines sample size, and was reached in 
this study, with 22 women.
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 The purpose and scope of the study were explained and 
informed voluntary consent was obtained. Each of the 22 
women subsequently participated in a tape-recorded, private, 
45- to 60-minute, in-depth, semi-structured interview on the 
hospital ward, which began with the general question “please 
tell me how you decided to agree to have this particular 
surgery”, followed by prompts encouraging elaboration.
Analysis
Analytic rigour was maintained by focusing the initial coding 
and classification on the research topic, close adherence to the 
research process, the evolution of codes, categories, and theory 
in order to allow others to understand how analytic decisions 
were made. Two researchers independently coded the data and 
held joint interpretive discussions. Disagreement was resolved 
by repeated textual reference, comparison, plausibility, and 
discussion. Validation involved sharing interpretations with, 
and reviewing of the data by, the participants through ongoing 
telephone follow-up interviews over the study period. All 
transcripts were analysed in their original Cantonese form. 
Illustrative quotes were translated subsequently.
Results
All except one woman were interviewed within 3 days 
postoperatively. Five women had stage 0 (ductal carcinoma 
in situ), four had stage I, eight had stage II, and five had 
stage III disease. Of the 22 participants, 15 had been offered 
a choice of surgical interventions: four were offered MRM 
only, two were offered BCT only, and one was offered 
MRM but requested BCT. Of the 15 women who had a 
treatment choice, seven chose MRM, one chose MRM with 
a concurrent TRAM-flap breast reconstruction, and seven 
chose BCT. Of the seven who chose BCT, two had MRM 
later because of tumour infiltration.
 Of 22 participants aged between 23 and 88 years, none 
had a family history of BC, 13 were married, six single, 
and three widowed. Eleven had children aged from 5 
to 40 years. Five were housewives, nine were currently 
employed, four were retired, one was a student, one was
currently unemployed, and two had to stop working after 
the cancer.
 From the analysis of these women’s experiences, we 
derived a four-stage decision making model. The four 
decision stages are: causal conditions, gamble of treatment 
choice, anticipated consequences of choice, and influence 
of coping activities.
Causal conditions influencing the treatment decision 
making process
Two TDM causal conditions emerged: discovery of a breast 
abnormality and emotional responses to the diagnosis of 
BC.
 Discovery of a breast abnormality, usually a lump, pain 
or nipple discharge, was the beginning of the BC experience 
for some women. Their initial responses varied depending 
on how they made sense of their symptom(s). Their own 
and others’ experiences, along with media information 
influenced symptom interpretation. Women knowledgeable 
about BC were more sensitive to the symptom implications, 
prompting earlier consultation. A woman with recurrent 
BC said, “I felt the lump in my breast when examining my 
breast. So I made an appointment to see my doctor the 
next day.” (Mrs L, 35 years). One woman said her decision 
to seek medical opinion was related to the current social 
marketing of BC awareness in Hong Kong, “I found a lump 
in my breast…. I’ve heard so many stories (in the media). 
Therefore, I decided to seek medical help.” (Mrs Q, 57 
years). However, personal experiences also led to some 
delaying medical consultation. Previous benign breast 
disease particularly desensitised several women to their 
symptoms, delaying treatment: “The symptom started a year 
ago. I found a lump in my breast…. I had a benign tumour 
3 years ago…. So I didn’t pay any attention.” (Miss N, 23 
years). Significant patient delay limited treatment options 
available to the doctor and hence TDM choices. “I was so 
worried that (the cancer) had already spread.... I waited 
for too long to seek medical advice…. I thought BCT is not 
good enough to control breast cancer…. I was worried so I 
decided to have MRM.” (Mrs K, 43 years). Early detection 
(including early medical consultation) increased treatment 
options for these women because of their early-stage BC 
and enhanced confidence in BCT. One woman who opted 
for BCT said, “I want to be able to preserve my breast…. It 
was discovered at a very early stage... therefore I believed 
it’s...unnecessary to have MRM….” (Mrs T, 50 years)
 The second causal condition influencing TDM was the 
emotional response to the breast cancer diagnosis. Women 
were usually provided with information about available 
surgical options immediately after receiving the diagnosis, 
a time when emotion impairs information processing.3 
Emotional responses included shock and fear of death. “At 
first, I couldn’t believe it. My surgeon (indicated) it was 
benign…. She didn’t say it could be malignant…. But it 
turned out that it was…. I couldn’t believe it. I was totally 
shocked.” (Mrs M, 27 years). Some women were at a loss to 
understand how they could have BC: “I kept asking myself: 
‘why this is happening to me?’ I couldn’t understand. I 
had no family history of breast cancer. I didn’t experience 
any signs and symptoms, apart from the lump.” (Miss C, 
53 years). So overwhelmed were they by the unanticipated 
diagnosis that many women were paralysed by the choices 
confronting them and could not respond: “My mind was 
totally blank. I was shocked as I never thought I would have 
cancer…. I found it really strange…. I couldn’t register any 
further information, my mind was blank…. My doctor tried 
to explain the treatment options but I couldn’t hear a single 
word.” (Mrs J, 59 years)
The process of treatment decision making
Deciding as gambling: because many factors could not be 
adequately estimated, the TDM process became a gamble 
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with life. “I was quite confused. It’s like going to a casino to 
gamble. It’s all dependant on your luck.” (Mrs L, 35 years)
 Discrepancies between women’s perceptions of 
‘rational’ choice and the rationalist models suggest these 
women reached their decisions based on informal, heuristic 
decision processes.8 This is exemplified by the experiential 
elements below.
Indecisiveness
• Uncertainty regarding the seriousness of the disease, 
together with the unanticipated threat of death from 
BC, made treatment choices very difficult to make: “I 
couldn’t make up my mind. I kept asking myself whether 
I should keep the breast or not. This was a constant 
struggle.” (Mrs A, 60 years)
• Asking responsibility for the treatment decision: women 
described their surgeons as opting out of the decision-
making process by not expressing a treatment opinion, 
simply asking them to choose between the given 
options. “The surgeon was unhelpful…they only told me 
the (treatment) consequences…then told me to choose 
one of the options...It was very impersonal.” (Mrs A, 60 
years)
• Inability to assimilate information: difficulties 
assimilating the surgeon’s information were common: 
“I was so confused. I didn’t pay attention…. To be 
honest, I wasn’t sure if my surgeon had explained the 
treatment options to me…because I didn’t listen. I was 
so frightened, I wasn’t interested to listen to the details.” 
(Mrs V, 40 years)
• Less distraught women also had problems asking 
questions, selecting, assimilating and clarifying the 
information given by their surgeons: “I didn’t know how 
to ask questions. I was listening to the biopsy report, as 
well as the surgeon’s advice. She kept asking me whether 
I understood or not. Of course, I understood what she 
was saying in that moment. But then I was overwhelmed 
with all the information. I was very confused.” (Miss P, 
46 years)
• Uncertainty about survival hindered these women’s 
abilities to identify the best treatment, further 
obstructing treatment decision information: “I asked 
my doctor about the chance of cancer recurrence (with) 
MRM…. She could only emphasise that my case is an 
early-stage disease. Then I asked her whether I need 
radiation therapy…. She told me that I had to wait for 
the... pathology report. It wasn’t very clear.” (Miss P, 46 
years)
• Uncertainty about the necessity of surgery: some 
women doubted the necessity of surgery. Doubts about 
the necessity of the surgery were associated with loss 
of trust in the surgeon, due, for example, to concerns 
about experimental treatments or the financial motives 
of private surgeons. “I had second thoughts about the 
doctor’s advice.... I don’t entirely trust the doctors as I 
am worried that they would want to use me to test new 
treatments.” (Miss N, 23 years)
Prioritising personal aims
The process of reviewing and weighing factors considered 
significant influences in the treatment decision. 
 Three key illness context factors influenced TDM:
• Perceived seriousness: none of the women considered 
refusing surgery. Their decision situation was, starkly, 
a choice between life and death: “…you have to do 
something...for example if you know you are carrying 
a bomb, you would want to get rid of it.” (Miss E, 36 
years). Secondly, women needed to select BCT or 
MRM. Evaluating the seriousness of their disease was 
one of the strategies women used to assess the necessity 
of having MRM. “If I was really worried, I could have 
the entire breast removed. But I thought my condition 
was not that bad. I’m not sure…that is what I believed. 
Now, I just have to wait for the (clinical pathology) 
report.” (Miss E, 36 years)
• Surviving is the highest stake: survival was assigned 
the highest priority by these women. “I found a lump 
in October, then I had surgery in November. The only 
thing in my mind was preserving my life.” (Mrs L, 35 
years). Losing a breast was an acceptable trade-off for 
survival, freedom from both cancer and the organ in 
which it arose. Several women incorrectly believed that 
no breast meant that recurrence was impossible. This 
desire for cure contributed to formulating a tolerable 
choice: “Having the entire breast removed could prevent 
cancer recurrence.” (Miss P, 46 years)
• The extent of suffering: weighing the extent of suffering 
also influenced TDM: “I was very hesitant about 
accepting the surgery. I didn’t want to suffer. I thought 
the operation would be very painful.” (Mrs I, 63 years). 
Minimising suffering by avoiding subsequent treatments 
was an influential TDM consideration. “If I want to 
preserve my breast, I needed to have chemotherapy 
first. I didn’t want to have chemotherapy…. So I decided 
to have MRM as it is possible that I might not need 
chemotherapy.” (Miss N, 23 years)
 Three social contextual factors influenced the TDM 
process:
• Preserving personal identity: our sense of self is 
physically embodied. Body image is a key facet of 
self-representation. Although many women traded-
off their breast for health and survival, disfigurement 
significantly threatened their sense of self. Therefore, 
the surgical decision created a psychological dilemma 
between cosmesis and survival. The distress of the 
anticipated body disfigurement, the stigma that the scar 
represents forever separates these women from those 
who are normal: “It was very tough to make the decision. 
I didn’t want to lose my breast. I didn’t want to look like 
an alien. I don’t want to be different from those who are 
normal.” (Miss N, 23 years). In contrast, concerns about 
a poor cosmetic outcome after BCT discouraged other 
women: “I’ve looked at pictures (of the cosmetic effects 
with BCT, as well as MRM)…. The appearance looks 
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rough…. It actually looks better without the breast.” 
(Miss P, 46 years)
• Preserving personal relationships with significant 
others: partners’ opinions on the treatment options were 
particularly influential: “My husband gave me a lot of 
confidence (in deciding to have bilateral mastectomy). 
It was very important to know how he thought about 
the effects of the surgery on our sex life. He reassured 
me that it was the right decision.” (Mrs U, 41 years). 
Older and/or widowed women showed less interest in 
preserving their breasts and felt ‘too old’ to worry about 
their body image and their husband’s opinions. “I am too 
old to worry about my appearance…. Being attractive is 
unimportant to me…. It’s more important for me to look 
normal.” (Mrs A, 60 years)
• Minimising life disruption: many women chose treatment 
options that were least disruptive to their routines. Most 
simply wanted to return to normal as soon as possible. 
“I chose the surgery based on the one that had the least 
disruption to my life.” (Miss E, 36 years)
 Adjuvant therapy was viewed as an obstacle to regaining 
normality and they gambled that MRM minimised their 
chances of having adjuvant therapy. “I really don’t want to 
have chemotherapy. I am hoping that having MRM would 
be good enough…. I’m just hoping for the best.” (Mrs A, 60 
years)
 Treatment impact on the family was another 
consideration. Family obligations dictated decisions 
considered best for their families.
Seeking and evaluating information
• Family discussions: BC was a family matter. Family 
members, particularly husbands, played a significant 
role in the decision making process. “I mainly discussed 
with my family. I asked my sisters…as both are nurses. 
I had great confidence in (them). I was so confused.” 
(Mrs U, 41 years)
• Identifying surgeons’ preference: those who trusted their 
surgeons’ knowledge and expertise tended to adopt their 
surgeon’s treatment recommendation. “I followed my 
surgeon’s advice. This was probably the best approach. 
Nobody knows better than your doctor.” (Mrs F, 39 
years)
• Relating to previous memories: past experiences of 
friends and relatives who had faced cancer influenced 
some women’s treatment choices. “My daughter’s friend 
had bilateral mastectomy. She was only 30 years old. I 
thought if she could accept the surgery, I figured that 
I could…so I decided to have the MRM.” (Mrs Q, 57 
years)
• Seeking a second expert opinion: second opinions 
from medical friends or family physicians provided 
reassurance. “I asked my surgeon to give me the clinical 
report and showed it to my medical friend…who is a 
gynaecologist, as well as my Chinese herbalist. Both of 
them told me to have the surgery.” (Mrs I, 63 years)
• Reviewing written materials: written information 
provided by the hospital was considered impersonal by 
some women and did not facilitate TDM, “You couldn’t 
make a decision based on the information (in the 
pamphlet). It only explained different treatments and the 
possible effects of the treatments.” (Mrs B, 36 years)
Time pressure
• All women in the present study felt that they made 
the decision very quickly. Some women said they 
were pressured to make a quick decision by health 
professionals or their families. “The staff told me to 
make the decision as soon as possible, the sooner, the 
better. So I called back within a week…. It was a bit 
rushed.” (Mrs B, 36 years)
• Some women wanted the operation as soon as possible, 
to get rid of the cancer and to return to normal. “My 
surgeon told me to take time to think about the options. 
It was a hard decision. I wanted to have the operation 
as soon as possible, while I couldn’t decide between the 
options.” (Mrs J, 59 years)
Consequences of making the treatment decision
Many women were emotionally overwhelmed while waiting 
for the surgery and their postoperative clinical pathology 
results.
• Fear of death: Once the decision was made, waiting lists 
often delayed surgery for 2 to 4 weeks. Preoccupation 
with fear of death made treatment delays especially 
difficult to cope with: “I was very down. I felt hopeless. I 
thought I didn’t have a chance to recover. I was worried 
that the cancer had spread. I felt very sick. I had pain 
and hot flushes. I felt that I was waiting for a death 
sentence.” (Mrs K, 43 years)
• Paying the price of the treatment choice: women choosing 
MRM talked about their unwillingness to relinquish 
their breast. “I would caress my breasts from time to 
time. I didn’t want to let them go.” (Mrs U, 41 years). 
Women who chose BCT suffered greater uncertainty 
about firstly, whether they would have to undergo MRM 
due to failed BCT operative margins and secondly, risk 
of disease recurrence. “I’m worried about what is going 
to happen next…the (pathology) report is really the final 
diagnosis. I know all of the possible outcomes. I heard 
from other women during the hospitalisation…. It’s just 
worrying.” (Miss O, 38 years)
• Living in uncertainty: confirmation of the disease stage 
usually depends on the pathology report, which is not 
available for several weeks after surgery, forcing women 
to wait and live in uncertainty. “I am really worried 
about my (pathology) report. I didn’t ask my surgeon, as 
I was so afraid that she would tell me bad news…. The 
prognosis couldn’t be confirmed without the report.” 
(Mrs K, 43 years)
Coping with the uncertainty
In order to keep from being overwhelmed by fear and un-
certainty, women utilised emotion-focused coping strategies.
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• Keeping busy: distraction, for instance through work 
or companionship, was a common strategy. “(While 
waiting for the operation,) I continued to go to work. I 
didn’t let myself think about it. I kept myself very busy. If 
I stayed at home, I would think a lot of things…all kinds 
of terrible scenes.” (Mrs Q, 57 years)
• Being optimistic: a few women described how they 
managed to think positively: “I am feeling better after 
the operation. I told myself that at least I would live for 
another 5 years. I thought I wouldn’t be that unlucky.” 
(Mrs K, 43 years)
• Fatalism: another common strategy used to manage 
emotions was to adopt a fatalistic stance. “If it happens, 
it happens. I am very calm.” (Mrs A, 60 years)
• Social comparison: upward comparisons with others 
who seemed to be coping well provided reassurance that 
they too would be able to cope. “I met a woman in the 
hospital. She was having chemotherapy. She seemed to 
be coping well with the side effects.... She had hair loss 
and was nauseated as well. But she handled the side-
effects very well. I thought if she could cope well, so can 
I.” (Mrs Q, 57 years)
Discussion
These data expose the processes women endure in their 
journey through the breast cancer treatment decision-making 
process. Deciding on treatment is like gambling, Russian 
roulette, where the outcome is either death or survival. The 
implications for clinical practice in the management of women 
facing breast cancer are that more can be done in the clinical 
consultation to minimise unnecessary stress and difficulties 
by ‘tuning’ how women are given information and when this 
information is given. The data illustrate very clearly that the 
doctor-patient relationship is at the heart of the provision of 
optimal care for these women at this most difficult time.
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